Targeted Genetics Corporation to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

SEATTLE, WA--(Marketwire - November 01, 2007) - Targeted Genetics Corporation (NASDAQ: TGEN) today announced that H. Stewart Parker, president and chief executive officer of Targeted Genetics, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference, Monday, November 5 at 3:00 p.m. Pacific Time at The Palace Hotel in New York. Ms. Parker will provide a corporate overview and discuss the Company’s product development program for inflammatory arthritis.

MORE ON THIS TOPIC